Cargando…
Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection
Respiratory syncytial virus (RSV) is a seasonal pathogen responsible for the highest percentage of viral bronchiolitis in pediatric patients. There are currently no vaccine available and therapeutic methods to mitigate the severity of RSV bronchiolitis are limited. OM-85, an oral standardized bacter...
Autores principales: | Antunes, Krist Helen, Cassão, Gisele, Santos, Leonardo Duarte, Borges, Sofia Giacomet, Poppe, Juliana, Gonçalves, João Budelon, Nunes, Eduarda da Silva, Recacho, Guilherme Fernando, Sousa, Vitória Barbosa, Da Silva, Gabriela Souza, Mansur, Daniel, Stein, Renato T., Pasquali, Christian, De Souza, Ana Paula Duarte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118194/ https://www.ncbi.nlm.nih.gov/pubmed/35603159 http://dx.doi.org/10.3389/fimmu.2022.867022 |
Ejemplares similares
-
Use of the Bacterial Lysate OM-85 in the Paediatric Population in Italy: A Retrospective Cohort Study
por: Cantarutti, Anna, et al.
Publicado: (2021) -
The OM-85 bacterial lysate: a new tool against SARS-CoV-2?
por: Pivniouk, Vadim, et al.
Publicado: (2023) -
Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study
por: Bodemer, Christine, et al.
Publicado: (2017) -
Bacterial lysates (OM-85 BV): a cost-effective proposal in order to contrast antibiotic resistance
por: TROIANO, GIANMARCO, et al.
Publicado: (2021) -
OM-85 is an immunomodulator of interferon-β production and inflammasome activity
por: Dang, A. T., et al.
Publicado: (2017)